REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Polrentgen" Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: "Polrentgen" Sp. z o.o. Profile Updated: January 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

"Polrentgen" Sp. z o.o develops and sells ultrasonography equipment for veterinary and medical use, with a focus on urological offices. Their products include stable, wheeled, and portable ultrasonographs. The company's target market is the medical rehabilitation industry.

Headquarters
Ul. Skarbka Z Gor 67/16
Warsaw; Mazowieckie; Postal Code: 03-287

Contact Details: Purchase the "Polrentgen" Sp. z o.o. report to view the information.

Website: http://www.polrentgen.pl

Basic Information
Total Employees:
Purchase the "Polrentgen" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Polrentgen" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Polrentgen" Sp. z o.o. report to view the information.
Incorporation Date:
January 09, 2002
Key Executives
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Prezes ­ Czlonek Zarzadu
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after "Polrentgen" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
12.43%▲
Total operating revenue
11.9%▲
Operating profit (EBIT)
-20.06%▼
EBITDA
-61.75%▼
Net Profit (Loss) for the Period
-21.73%▼
Total assets
-6.98%▼
Total equity
-4.41%▼
Operating Profit Margin (ROS)
-0.53%▼
Net Profit Margin
-0.69%▼
Return on Equity (ROE)
-0.99%▼
Debt to Equity Ratio
-0.46%▼
Quick Ratio
6.11%▲
Cash Ratio
1.81%▲

Similar companies

"Farmacol" S.A.
 
Gsk Services Sp. z o.o.
Super-Pharm Poland Sp. z o.o.
 
Acs Audika Sp. z o.o.
Przedsiebiorstwo Zaopatrzenia Farmaceutycznego "Cefarm-Warszawa" S.A.
 
Sonova Audiological Care Polska Sp. z o.o.
Medivetcon Sp. z o.o.
 
Nuga Health Sp. z o.o.
Optyka Rekas Agnieszka I Piotr Rekas Sp. z o.o.
 
"Neuro-Optimal" Sp. z o.o.
Centrum Ortopedyczne Ortocool Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo